 |
EnteroMedics
Dan Gladney, CEO
USA | Funding: $161.2M (+)
Website: http://enteromedics.com/
EnteroMedics is the developer of in-class weight loss treatments for obesity and obesity related risk factors.
Website: http://enteromedics.com/
EnteroMedics is the developer of in-class weight loss treatments for obesity and obesity related risk factors.
